Boston Scientific to enhance urology portfolio by acquiring Axonics in $3.7bn deal
Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire Axonics, Inc. (Nasdaq: AXNX), a leading medical technology company specializing in urinary ... Read More
Boston Scientific wraps up $1bn acquisition of Lumenis surgical business
Boston Scientific has wrapped up the previously announced $1.07 billion acquisition of the global surgical business of Israeli medical solutions provider Lumenis. The US medical ... Read More
Boston Scientific to acquire Lumenis surgical business for $1bn
Boston Scientific has agreed to acquire the global surgical business of Israel-based energy-based medical solutions provider Lumenis for $1.07 billion in cash. In this connection, ... Read More